(Q42703745)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

editorial

0 references

title

Chemotherapy for ovarian cancer--a consensus statement on standard practice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Adams

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

A H Calvert

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J Carmichael

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P I Clark

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R E Coleman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C J Gallagher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

T S Ganesan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M E Gore

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P G Harper

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

S B Kaye

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J A Ledermann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

R J Osborne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

C J Poole

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G J Rustin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M L Slevin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J F Smyth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

H Thomas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

P M Wilkinson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

7 December 2019

http://eprints.whiterose.ac.uk/100567/

content deliverer

White Rose Research Online

object of statement has role

published version

0 references

https://doi.org/10.1038/bjc.1998.699

object of statement has role

published version

0 references

published in

British Journal of Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1404-1406

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

Advanced epithelial ovarian cancer: 1993 consensus statements

7 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Management of ovarian cancer: referral to a multidisciplinary team matters

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Paclitaxel (Taxol) treatment for refractory ovarian cancer: phase II clinical trial.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Paclitaxel (Taxol) in heavily pretreated ovarian cancer: antitumor activity and complications

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063222

Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9836470

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

European-Canadian randomized trial of paclitaxel in relapsed ovarian cancer: high-dose versus low-dose and long versus short infusion

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9836470

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/BJC.1998.699

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 December 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

PubMed publication ID

9836470

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836470%20AND%20SRC:MED&resulttype=core&format=json